Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer

Background: Within the claudin (CLDN) family, CLDN12 mRNA expression is altered in various types of cancer, but its clinicopathological relevance has yet to be established due to the absence of specific antibodies (Abs) with broad applications. Methods: We generated a monoclonal Ab (mAb) against hum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Rahman, Abidur, Kobayashi, Makoto, Sugimoto, Kotaro, Endo, Yuta, Kojima, Manabu, Furukawa, Shigenori, Watanabe, Takafumi, Soeda, Shu, Hashimoto, Yuko, Fujimori, Keiya, Chiba, Hideki
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8038723/
https://ncbi.nlm.nih.gov/pubmed/33917356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22073774
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados